Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Larson

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Handbook of Experimental Pharmacology|January 29, 2019
Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and TreatmentChristopher J Larson
Expert Review of Endocrinology & Metabolism|February 13, 2019
The persistent need for insulin sensitizers and other disease-modifying anti-diabetic drugsChristopher J Larson
Handbook of Experimental Pharmacology|April 24, 2015
cGMP and Brown Adipose TissueLinda S Hoffmann, Christopher J Larson, Alexander Pfeifer
Circulation Research|April 25, 2015
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery diseaseWilliam R Hiatt, Ehrin J Armstrong, Christopher J Larson, et al.
Journal of Biomolecular Screening|June 9, 2006
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometryJon R Inglefield, Christopher J Larson, Sheila J Gibson, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|October 2, 2007
Refusals, denials, and patient choice: reasons prospective patients do not undergo bariatric surgerySubramaniam Sadhasivam, Christopher J Larson, Pamela J Lambert, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 11, 2008
Number of weight loss attempts and maximum weight loss before Roux-en-Y laparoscopic gastric bypass surgery are not predictive of postoperative weight lossEmily J Jantz, Christopher J Larson, Michelle A Mathiason, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 4, 2010
BAROS results in 700 patients after laparoscopic Roux-en-Y gastric bypass with subset analysis of age, gender, and initial body mass indexAyman B Al Harakeh, Christopher J Larson, Michelle A Mathiason, et al.
Current Cardiology Reports|October 2, 2021
Atrial Fibrillation Genomics: Discovery and TranslationDavid H Yoo, Rolf Bodmer, Karen Ocorr, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Length of stay and impact on readmission rates after laparoscopic gastric bypassMatthew T Baker, Michael D Lara, Christopher J Larson, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Handbook of Experimental Pharmacology|January 29, 2019
Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and TreatmentChristopher J Larson
Expert Review of Endocrinology & Metabolism|February 13, 2019
The persistent need for insulin sensitizers and other disease-modifying anti-diabetic drugsChristopher J Larson
Handbook of Experimental Pharmacology|April 24, 2015
cGMP and Brown Adipose TissueLinda S Hoffmann, Christopher J Larson, Alexander Pfeifer
Circulation Research|April 25, 2015
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery diseaseWilliam R Hiatt, Ehrin J Armstrong, Christopher J Larson, et al.
Journal of Biomolecular Screening|June 9, 2006
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometryJon R Inglefield, Christopher J Larson, Sheila J Gibson, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|October 2, 2007
Refusals, denials, and patient choice: reasons prospective patients do not undergo bariatric surgerySubramaniam Sadhasivam, Christopher J Larson, Pamela J Lambert, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|November 11, 2008
Number of weight loss attempts and maximum weight loss before Roux-en-Y laparoscopic gastric bypass surgery are not predictive of postoperative weight lossEmily J Jantz, Christopher J Larson, Michelle A Mathiason, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 4, 2010
BAROS results in 700 patients after laparoscopic Roux-en-Y gastric bypass with subset analysis of age, gender, and initial body mass indexAyman B Al Harakeh, Christopher J Larson, Michelle A Mathiason, et al.
Current Cardiology Reports|October 2, 2021
Atrial Fibrillation Genomics: Discovery and TranslationDavid H Yoo, Rolf Bodmer, Karen Ocorr, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Length of stay and impact on readmission rates after laparoscopic gastric bypassMatthew T Baker, Michael D Lara, Christopher J Larson, et al.
Pageof 4